SERGIO MENENDEZ-APONTE: Open Payments
NPI 1609897305 · WINTER PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,443 in 134 payments from 29 companies in 2025. Trend: 2023 $1,961 · 2024 $2,276 · 2025 $3,443
Food & beverage: $3,344Education: $99
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 11 | $506 |
| Novo Nordisk Inc | 24 | $433 |
| AstraZeneca Pharmaceuticals LP | 10 | $329 |
| Amgen Inc. | 17 | $245 |
| Otsuka America Pharmaceutical, Inc. | 2 | $238 |
| PFIZER INC. | 7 | $222 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $211 |
| ABBVIE INC. | 14 | $193 |
| Lilly USA, LLC | 2 | $132 |
| Lundbeck LLC | 5 | $120 |
Products named: Auvelity, REXULTI, CAPLYTA, ELIQUIS, AIRSUPRA, Rybelsus, KISUNLA, Wegovy.
Industry payments across FL — which companies pay providers there.
